soul trial oral semaglutide cardiovascular outcomes results 2025 (NEJM 2025): led to a 14% ↓ in major CV events vs placebo in T2DM with ASCVD or CKD — no ↑ in serious AEs. #Semaglutide #CardioDiabetes #updatesinmedicine The SOUL Study - by
Pay in 4 interest-free payments of $5.48 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9























![Centurion Pro Exhaust Gladiator Replacement Part CP-5031 [20214] Cloning Equipment_Cloning Carts](https://cdn.shopify.com/s/files/1/0856/1428/products/20214.jpg?v=1740155053)



